Impact of tacrolimus variability on pediatric heart transplant outcomes.

Megan Sirota Caroline Heyrend Zhining OuSusan MasottiEric R Griffiths Kimberly M Molina

Published in: Pediatric transplantation (2021)

ETLV is prevalent in the pediatric HT population with increased frequency of poor outcomes in those with SD ≥3. ETLV is an easily accessible marker with which to risk-stratify patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
peritoneal dialysis
prognostic factors
atrial fibrillation
metabolic syndrome
glycemic control
young adults